NCT04120402 - Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee | Biotech Hunter

Enrollment

318

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

May 17, 2023

Study Completion Date

June 1, 2023

Conditions

Osteoarthritis, Knee

Interventions

DRUG

EP-104IAR 25 mg

Single 5 mL intra-articular injection

DRUG

Vehicle

Single 5 mL intra-articular injection

Trial Locations (12)

CCR Brno, s.r.o, Brno

CCR Czech a.s, Pardubice

CCR Prague, s.r.o, Prague

The Parker Institute, Frederiksberg Hospital, Frederiksberg

Sanos Clinic Nordjylland, Gandrup

Sanos Clinic Herlev, Herlev

Sanos Clinic Syddanmark, Vejle

NZOZ BIF-MED s.c, Bytom

Somed CR, Lodz

Medyczne Centrum Hetmańska, Poznan

DC-MED, Swidnica

Somed CR, Warsaw